Measles, mumps, rubella prevention: how can we do better?-Reference-Cited by-同舟云学术

Measles, mumps, rubella prevention: how can we do better?

Published:2021-06-07 Issue:7 Volume:20 Page:811-826
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Kauffmann Florence¹^ORCID,Heffernan Catherine²^ORCID,Meurice François¹³^ORCID,Ota Martin O. C.¹^ORCID,Vetter Volker¹^ORCID,Casabona Giacomo¹^ORCID

Affiliation:

1. GSK, Avenue Fleming 20, 1300 Wavre, Belgium

2. NHS England (London Region), 1st Floor, Wellington House, 133-155 Waterloo Road, London, SE16UG, UK

3. Biomedical Sciences Department, Faculty of Medicine, University of Namur (UNamur), Rue de Bruxelles 61, 5000 Namur, Belgium

Funder

GlaxoSmithKline Biologicals

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1927722

Reference199 articles.

1. World Health Organization. Global measles and rubella strategic plan: 2012-2020. World Health Organization, Geneva, 2012. [cited 2020 Aug 19]. Available from https://apps.who.int/iris/bitstream/handle/10665/44855/9789241503396_eng.pdf?sequence=1

2. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood

3. World Health Organization. Global vaccine action plan 2011–2020. WHO Library Cataloguing-in-Publication Data. 2013. [cited 2020 Mar 12]. Available from https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socio-demographic factors affecting the first and second dose of measles vaccination status among under-five children: Perspectives from South Asian countries;Preventive Medicine Reports;2024-09

2. Epidemiological characteristics and serological survey of mumps 15 years after MMR vaccine was included in the immunization program;Journal of Medical Virology;2024-08

3. Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective;Nature Communications;2024-07-03

4. Measles in the vaccinated host;BMJ Case Reports;2024-07

5. Determinants of second-dose measles vaccination dropout in Ethiopia: A community-based matched case-control study;Heliyon;2024-05